These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 26297994)
1. Combining a PagP fusion protein system with nickel ion-catalyzed cleavage to produce intrinsically disordered proteins in E. coli. Zahran S; Pan JS; Liu PB; Hwang PM Protein Expr Purif; 2015 Dec; 116():133-8. PubMed ID: 26297994 [TBL] [Abstract][Full Text] [Related]
2. A PagP fusion protein system for the expression of intrinsically disordered proteins in Escherichia coli. Hwang PM; Pan JS; Sykes BD Protein Expr Purif; 2012 Sep; 85(1):148-51. PubMed ID: 22841980 [TBL] [Abstract][Full Text] [Related]
3. Targeted expression, purification, and cleavage of fusion proteins from inclusion bodies in Escherichia coli. Hwang PM; Pan JS; Sykes BD FEBS Lett; 2014 Jan; 588(2):247-52. PubMed ID: 24076468 [TBL] [Abstract][Full Text] [Related]
4. Refinement of the Fusion Tag PagP for Effective Formation of Inclusion Bodies in Escherichia coli. Li X; Zhang B; Hu Q; Chen C; Huang J; Liu L; Wang S Microbiol Spectr; 2023 Jun; 11(3):e0380322. PubMed ID: 37222613 [TBL] [Abstract][Full Text] [Related]
5. Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform. Hsieh SK; Yu YJ; Tang NY; Lin JR; Jinn TR Protein Pept Lett; 2017; 24(11):1021-1029. PubMed ID: 28741464 [TBL] [Abstract][Full Text] [Related]
6. InSiDDe: A Server for Designing Artificial Disordered Proteins. Schramm A; Lieutaud P; Gianni S; Longhi S; Bignon C Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286306 [TBL] [Abstract][Full Text] [Related]
7. Application of an E. coli signal sequence as a versatile inclusion body tag. Jong WS; Vikström D; Houben D; van den Berg van Saparoea HB; de Gier JW; Luirink J Microb Cell Fact; 2017 Mar; 16(1):50. PubMed ID: 28320377 [TBL] [Abstract][Full Text] [Related]
8. Recombinant production of biologically active giant grouper (Epinephelus lanceolatus) growth hormone from inclusion bodies of Escherichia coli by fed-batch culture. Chung WJ; Huang CL; Gong HY; Ou TY; Hsu JL; Hu SY Protein Expr Purif; 2015 Jun; 110():79-88. PubMed ID: 25703054 [TBL] [Abstract][Full Text] [Related]
9. [An effective scheme to produce recombinant uracil-DNA glycosylase of Escherichia coli for PCR diagnostics]. Dmitrochenko AE; Turiianskaia OM; Gilep AA; Usanov SA; Iantsevich AV Prikl Biokhim Mikrobiol; 2014; 50(4):398-407. PubMed ID: 25707116 [TBL] [Abstract][Full Text] [Related]
10. Synthetic intrinsically disordered protein fusion tags that enhance protein solubility. Tang NC; Su JC; Shmidov Y; Kelly G; Deshpande S; Sirohi P; Peterson N; Chilkoti A Nat Commun; 2024 May; 15(1):3727. PubMed ID: 38697982 [TBL] [Abstract][Full Text] [Related]
11. Purification of inclusion body-forming peptides and proteins in soluble form by fusion to Escherichia coli thermostable proteins. Thapa A; Shahnawaz M; Karki P; Raj Dahal G; Sharoar MG; Yub Shin S; Sup Lee J; Cho B; Park IS Biotechniques; 2008 May; 44(6):787-96. PubMed ID: 18476832 [TBL] [Abstract][Full Text] [Related]
12. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein. Salema V; Fernández LÁ Protein Expr Purif; 2013 Sep; 91(1):42-8. PubMed ID: 23856605 [TBL] [Abstract][Full Text] [Related]
13. Efficient production of recombinant cystatin C using a peptide-tag, 4AaCter, that facilitates formation of insoluble protein inclusion bodies in Escherichia coli. Hayashi M; Iwamoto S; Sato S; Sudo S; Takagi M; Sakai H; Hayakawa T Protein Expr Purif; 2013 Apr; 88(2):230-4. PubMed ID: 23396100 [TBL] [Abstract][Full Text] [Related]
14. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies. Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671 [TBL] [Abstract][Full Text] [Related]
15. Expression, purification and NMR characterization of the cyclic recombinant form of the third intracellular loop of the vasopressin type 2 receptor. Bellot G; Pascal R; Mendre C; Urbach S; Mouillac B; Déméné H Protein Expr Purif; 2011 Aug; 78(2):131-8. PubMed ID: 21575724 [TBL] [Abstract][Full Text] [Related]
16. Clusters in an intrinsically disordered protein create a protein-binding site: the TolB-binding region of colicin E9. Tozawa K; Macdonald CJ; Penfold CN; James R; Kleanthous C; Clayden NJ; Moore GR Biochemistry; 2005 Aug; 44(34):11496-507. PubMed ID: 16114886 [TBL] [Abstract][Full Text] [Related]
17. Rational recombinant XMRV antigen preparation and bead coupling for multiplex serology in a suspension array. Sheikholvaezin A; Blomberg F; Ohrmalm C; Sjösten A; Blomberg J Protein Expr Purif; 2011 Dec; 80(2):176-84. PubMed ID: 21871964 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human insulin. VIII. Isolation of fusion protein--S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells. Tikhonov RV; Pechenov SE; Belacheu IA; Yakimov SA; Klyushnichenko VE; Boldireva EF; Korobko VG; Tunes H; Thiemann JE; Vilela L; Wulfson AN Protein Expr Purif; 2001 Feb; 21(1):176-82. PubMed ID: 11162404 [TBL] [Abstract][Full Text] [Related]
19. An efficient procedure for the expression and purification of HIV-1 protease from inclusion bodies. Nguyen HL; Nguyen TT; Vu QT; Le HT; Pham Y; Trinh PL; Bui TP; Phan TN Protein Expr Purif; 2015 Dec; 116():59-65. PubMed ID: 26231073 [TBL] [Abstract][Full Text] [Related]
20. EspA is a novel fusion partner for expression of foreign proteins in Escherichia coli. Cheng Y; Gu J; Wang HG; Yu S; Liu YQ; Ning YL; Zou QM; Yu XJ; Mao XH J Biotechnol; 2010 Nov; 150(3):380-8. PubMed ID: 20854850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]